Influence of pharmaceutical care on the delayed emesis associated with chemotherapy

[1]  T. Koizumi,et al.  [Incidence of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-including chemotherapy]. , 2013, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  K. Yap,et al.  Assessment of the Relationship Between Adherence with Antiemetic Drug Therapy and Control of Nausea and Vomiting in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy , 2012, Journal of managed care pharmacy : JMCP.

[3]  J. M. Baena-Cañada,et al.  Análisis de la efectividad de un protocolo de antiemesis implantado en la Unidad de Oncología , 2010 .

[4]  M. Suzui,et al.  Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients , 2010, Supportive Care in Cancer.

[5]  J. Leonard,et al.  Outcome of deferred initial therapy in mantle-cell lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  N. Barber,et al.  Patient-centred advice is effective in improving adherence to medicines , 2006, Pharmacy World and Science.

[7]  M. Kris,et al.  American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Dowse,et al.  Medicines information and adherence in HIV/AIDS patients , 2006, Journal of clinical pharmacy and therapeutics.

[9]  I. Uriarte,et al.  Informacion al paciente para mejorar el control de la emesis retardada , 2002 .

[10]  D. Carney,et al.  Chemotherapy induced nausea and vomiting. , 1994, Irish medical journal.